Navigation Links
Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
Date:4/14/2008

Newly Designed Blood Glucose Meter Easier to Read and Offers

Next-Generation Benefits that Can Help People Improve Their Diabetes

Management

ABBOTT PARK, Ill., April 14 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the availability of the FreeStyle Freedom(R) Lite Blood Glucose Monitoring System (http://www.abbottdiabetescare.com/). Offering all of the benefits of Abbott's FreeStyle family of glucose monitoring systems, the newly designed FreeStyle Freedom Lite system provides accurate, reliable results that can help improve diabetes management (http://www.diabetescontrolforlife.com/), which can ultimately lead to better health.

By combining features such as no manual coding, which eliminates one step in the testing process; the world's smallest sample size requirement (0.3 microliter), meaning less pain; and one of the largest displays in an easy-to-read, easy-to-use meter, the FreeStyle Freedom Lite system gives people with diabetes a new option to help simplify their diabetes management routine.

"Diabetes is a unique health condition in that it requires a high degree of self-management," said Lorena Drago, MS, RD, CDN, CDE. "A glucose monitoring device that's easy to use and delivers quick, accurate results can be an invaluable asset in helping a person gain control of their diabetes today, and their long-term health tomorrow."

The FreeStyle Freedom Lite Blood Glucose Monitoring System is available with an instructional video and product brochure in both English and Spanish.

About Abbott Diabetes Care

Abbott Diabetes Care, based in Alameda, Calif., is a leader in developing, manufacturing and marketing glucose monitoring systems designed to help people better manage their diabetes. Abbott Diabetes Care is committed to developing products that reduce the discomfort and inconvenience of glucose monitoring and introducing systems that are easier to use, require smaller samples and provide faster results.

Abbott Diabetes Care markets several leading-edge glucose monitoring systems and test strips in the United States for use in both home and hospital settings; leading brands include FreeStyle(R) Lite, FreeStyle Freedom(R) Lite, FreeStyle Freedom(TM), FreeStyle Flash(R) and Precision Xtra(TM), as well as its newest diabetes management tool, FreeStyle Navigator(R) Continuous Glucose Monitoring System. Additional information about Abbott Diabetes Care may be found at http://www.abbottdiabetescare.com.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 68,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology: